Coronally advanced flap combined with Geistlich Mucograft for the treatment of recession type defects: a randomized controlled clinical trial.

Withdrawn

• Conditions: recessiedefecten van gebitselementen; gingival recesssion; receding gums

• Registration Number: NL-OMON38205
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

1. Patients have to present in good general health
2. Only non-smokers will be included
3. Good oral hygiene, i.e. full-mouth plaque score (FMPS) < 20%
4. Low levels of residual periodontal infection, i.e. full-mouth bleeding score (FMBS) < 20%
5. Only patients with optimal compliance will be enrolled in the study
6. Patients have to be willing to adhere to a strict Supportive Periodontal Therapy (SPT) protocol
7. Patients must be candidate for recession coverage presenting at least one, maximum 5 maxillary Miller class I or II recession type defect(s)

Exclusion Criteria

1. Patients not fulfilling the inclusion criteria
2. Patient with uncontrolled or poorly controlled diabetes, using anticoagulants, presenting unstable or life-threatening conditions, or requiring antibiotic prophylaxis wil be exluded

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome variable will be recession depth (RECd). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome variables will be percentage of defect coverage, recession<br /><br>width (RECw), clinical attachment level (CAL), probing pocket depth (PPD), and<br /><br>width of keratinized tissue (KTw). </p><br>